The Graft-Versus-Myeloma Effect: Chronic Graft-Versus-Host Disease but Not Acute Graft-Versus-Host Disease Prolongs Survival in Patients with Multiple Myeloma Receiving Allogeneic TransplantationMichèle L. Donato, Scott D. Rowley, David S. Siegel et al.|Transplantation and Cellular Therapy|2014Cited by 54
Haploidentical Allogeneic Transplantation As Salvage in Relapsed Multiple MyelomaPhyllis McKiernan, Michèle L. Donato, Scott D. Rowley et al.|Blood|2014Cited by 3
Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL)Arpita P Gandhi, Scott D. Rowley, Michèle L. Donato et al.|Blood|2013Cited by 1
Long-Term Follow-up of Patients With Multiple Myeloma Who Received Allogeneic Hematopoietic Stem Cell TransplantationMichèle L. Donato, Scott D. Rowley, David S. Siegel et al.|Blood|2013Cited by 1
Unrelated Donor Hematopoietic Stem Cell Transplantation for the Treatment of Advanced Multiple Myeloma: The John Theurer Cancer Center Experience,Michèle L. Donato, Scott D. Rowley, David H. Vesole et al.|Blood|2011Cited by 0